skip to main content
Language:
Results 1 2 next page
Refined by: collection: Academic Search Premier (EB_SDU_P3) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
Material Type:
Article 		Add to e-Shelf

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Brown, J R ; Hillmen, P ; O'Brien, S ; Barrientos, J C ; Reddy, N M ; Coutre, S E ; Tam, C S ; Mulligan, S P ; Jaeger, U ; Barr, P M ; Furman, R R ; Kipps, T J ; Cymbalista, F ; Thornton, P ; Caligaris-Cappio, F ; Delgado, J ; Montillo, M ; DeVos, S ; Moreno, C ; Pagel, J M ; Munir, T ; Burger, J A ; Chung, D ; Lin, J ; Gau, L ; Chang, B ; Cole, G ; Hsu, E ; James, D F ; Byrd, J C

Leukemia, 2018-01, Vol.32 (1), p.83-91 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Citations Cited by
2
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
Material Type:
Article 		Add to e-Shelf

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

Wierda, William G ; Rawstron, Andrew ; Cymbalista, Florence ; Badoux, Xavier ; Rossi, Davide ; Brown, Jennifer R ; Egle, Alexander ; Abello, Virginia ; Cervera Ceballos, Eduardo ; Herishanu, Yair ; Mulligan, Stephen P ; Niemann, Carsten U ; Diong, Colin P ; Soysal, Teoman ; Suzuki, Ritsuro ; Tran, Hoa T T ; Wu, Shang-Ju ; Owen, Carolyn ; Stilgenbauer, Stephan ; Ghia, Paolo ; Hillmen, Peter

Leukemia, 2021-11, Vol.35 (11), p.3059-3072 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Citations Cited by
3
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
Material Type:
Article 		Add to e-Shelf

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Rawstron, A C ; Böttcher, S ; Letestu, R ; Villamor, N ; Fazi, C ; Kartsios, H ; de Tute, R M ; Shingles, J ; Ritgen, M ; Moreno, C ; Lin, K ; Pettitt, A R ; Kneba, M ; Montserrat, E ; Cymbalista, F ; Hallek, M ; Hillmen, P ; Ghia, P

Leukemia, 2013-01, Vol.27 (1), p.142-149 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Citations Cited by
4
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
Material Type:
Article 		Add to e-Shelf

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Rawstron, A C ; Fazi, C ; Agathangelidis, A ; Villamor, N ; Letestu, R ; Nomdedeu, J ; Palacio, C ; Stehlikova, O ; Kreuzer, K-A ; Liptrot, S ; O'Brien, D ; de Tute, R M ; Marinov, I ; Hauwel, M ; Spacek, M ; Dobber, J ; Kater, A P ; Gambell, P ; Soosapilla, A ; Lozanski, G ; Brachtl, G ; Lin, K ; Boysen, J ; Hanson, C ; Jorgensen, J L ; Stetler-Stevenson, M ; Yuan, C ; Broome, H E ; Rassenti, L ; Craig, F ; Delgado, J ; Moreno, C ; Bosch, F ; Egle, A ; Doubek, M ; Pospisilova, S ; Mulligan, S ; Westerman, D ; Sanders, C M ; Emerson, R ; Robins, H S ; Kirsch, I ; Shanafelt, T ; Pettitt, A ; Kipps, T J ; Wierda, W G ; Cymbalista, F ; Hallek, M ; Hillmen, P ; Montserrat, E ; Ghia, P

Leukemia, 2016-04, Vol.30 (4), p.929-936 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Citations Cited by
5
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100
Material Type:
Article 		Add to e-Shelf

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100

Le Roux, G ; Vlad, A ; Eclache, V ; Malanquin, C ; Collon, J-F ; Gantier, M ; Schillinger, F ; Peltier, J-Y ; Savin, B ; Letestu, R ; Baran-Marszak, F ; Fenaux, P ; Ajchenbaum-Cymbalista, Florence

International journal of laboratory hematology, 2010-12, Vol.32 (6 Pt 1), p.e237-e243 [Peer Reviewed Journal]

England

Full text available

Citations Cited by
6
Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL
Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL
Material Type:
Article 		Add to e-Shelf

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL

MAGNAC, C ; PORCHER, R ; DAVI, F ; NATAF, J ; PAYELLE-BROGARD, B ; TANG, R. P ; OPPEZZO, P ; LEVY, V ; DIGHIERO, G ; AJCHENBAUM-CYMBALISTA, F

Leukemia, 2003-01, Vol.17 (1), p.133-137 [Peer Reviewed Journal]

London: Nature Publishing

Full text available

Citations Cited by
7
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM
Material Type:
Article 		Add to e-Shelf

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM

LE ROUX, G. ; VLAD, A. ; ECLACHE, V. ; MALANQUIN, C. ; COLLON, J.-F. ; GANTIER, M. ; SCHILLINGER, F. ; PELTIER, J.-Y. ; SAVIN, B. ; LETESTU, R. ; BARAN-MARSZAK, F. ; FENAUX, P. ; AJCHENBAUM-CYMBALISTA, F.

International journal of laboratory hematology, 2010-12, Vol.32 (6p1), p.e237-e243 [Peer Reviewed Journal]

Oxford, UK: Blackwell Publishing Ltd

Full text available

Citations Cited by
8
Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia
Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia
Material Type:
Article 		Add to e-Shelf

Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia

BILLARD, C ; KERN, C ; TANG, R ; AJCHENBAUM-CYMBALISTA, F ; KOLB, J-P

Leukemia, 2003-12, Vol.17 (12), p.2435-2443 [Peer Reviewed Journal]

London: Nature Publishing

Full text available

Citations Cited by
9
Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases
Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases
Material Type:
Article 		Add to e-Shelf

Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases

SANHES, L ; TANG, R ; DELMER, A ; DECAPRIO, J. A ; AJCHENBAUM-CYMBALISTA, F

Leukemia, 2003-06, Vol.17 (6), p.1104-1111 [Peer Reviewed Journal]

London: Nature Publishing

Full text available

Citations Cited by
10
Flavopiridol downregulates the expression of both the inducible NO synthase and p27 in malignant cells from B-cell chronic lymphocytic leukemia
Flavopiridol downregulates the expression of both the inducible NO synthase and p27 in malignant cells from B-cell chronic lymphocytic leukemia
Material Type:
Article 		Add to e-Shelf

Flavopiridol downregulates the expression of both the inducible NO synthase and p27 in malignant cells from B-cell chronic lymphocytic leukemia

Billard, C ; Kern, C ; Tang, R ; Ajchenbaum-Cymbalista, F ; Kolb, J-P

Leukemia, 2003-12, Vol.17 (12), p.2435-2443 [Peer Reviewed Journal]

England

Full text available

Citations Cited by
Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Resource Type 

  1. Articles  (16)
  2. Conference Proceedings  (1)
  3. More options open sub menu

Creation Date 

From To
Refine
  1. Before1994  (2)
  2. 1994To2000  (2)
  3. 2001To2003  (5)
  4. 2004To2013  (5)
  5. After 2013  (4)
  6. More options open sub menu

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far